F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

Written by

in

The New York Times – Business:

The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.

RSS Feed
Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.